[A comparative evaluation of immunomodulating drugs in the treatment of remitting multiple sclerosis].
Zvartau
M E
ME
Kaon
K
K
Lisak
R F
RF
Kan
O A
OA
Skoromets
A A
AA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000068717:Glatiramer Acetate; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D010455:Peptides; D011994:Recombinant Proteins; D000068717:Glatiramer Acetate; D007372:Interferons